Amir Avniel
President bei BEYOND AIR, INC.
Vermögen: 762 167 $ am 31.03.2024
Profil
Amir Avniel is the founder of Beyond Air Ltd.
(founded in 2011) and Ait Ltd.
(founded in 2011).
He holds the title of Chief Business Officer at Beyond Air Ltd.
and Chief Executive Officer & Director at Ait Ltd.
Mr. Avniel's current job(s) include being the President, Director & Chief Business Officer at Beyond Air, Inc. (since 2017) and the Executive Director at Beyond Cancer, Ltd.
Mr. Avniel's former job(s) include being the President & Chief Executive Officer at Rosetta Genomics Ltd.
(2006-2009), President & Chief Executive Officer at G.F.C Green Fields Capital Ltd.
(2010-2013), Chairman at Enox Biopharma, Inc., and Head-Strategy & Business Development at AB Seeds Ltd.
(2013-2014).
Mr. Avniel's education history includes completing an undergraduate degree at The Open University of Israel.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
BEYOND AIR, INC.
1,22% | 20.03.2024 | 438 027 ( 1,22% ) | 762 167 $ | 31.03.2024 |
Aktive Positionen von Amir Avniel
Unternehmen | Position | Beginn |
---|---|---|
BEYOND AIR, INC. | President | 13.01.2017 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Founder | 01.05.2011 |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Founder | 01.01.2011 |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Director/Board Member | - |
Ehemalige bekannte Positionen von Amir Avniel
Unternehmen | Position | Ende |
---|---|---|
AB Seeds Ltd. | Corporate Officer/Principal | 01.01.2014 |
G.F.C GREEN FIELDS CAPITAL LTD. | Chief Executive Officer | 01.01.2013 |
ROSETTA GENOMICS LTD. | Chief Executive Officer | 01.01.2009 |
Enox Biopharma, Inc.
Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Enox Biopharma, Inc. operated in the development of Develops antimicrobial medical devices coated with Nitric Oxide. It products include urinary catheters, endotracheal tubes, central venous lines and other short term indwelling devices. The company was founded by Yossef Av-Gay on June 27, 2007 and is headquartered in Yehud-Monosson, Israel. | Chairman | - |
Ausbildung von Amir Avniel
The Open University of Israel | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ROSETTA GENOMICS LTD. | Health Technology |
G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
BEYOND AIR, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Enox Biopharma, Inc.
Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Enox Biopharma, Inc. operated in the development of Develops antimicrobial medical devices coated with Nitric Oxide. It products include urinary catheters, endotracheal tubes, central venous lines and other short term indwelling devices. The company was founded by Yossef Av-Gay on June 27, 2007 and is headquartered in Yehud-Monosson, Israel. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Health Technology |
AB Seeds Ltd. | |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Health Technology |